MYH11_HUMAN - dbPTM
MYH11_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MYH11_HUMAN
UniProt AC P35749
Protein Name Myosin-11
Gene Name MYH11
Organism Homo sapiens (Human).
Sequence Length 1972
Subcellular Localization Melanosome . Identified by mass spectrometry in melanosome fractions from stage I to stage IV. Thick filaments of the myofibrils.
Protein Description Muscle contraction..
Protein Sequence MAQKGQLSDDEKFLFVDKNFINSPVAQADWAAKRLVWVPSEKQGFEAASIKEEKGDEVVVELVENGKKVTVGKDDIQKMNPPKFSKVEDMAELTCLNEASVLHNLRERYFSGLIYTYSGLFCVVVNPYKHLPIYSEKIVDMYKGKKRHEMPPHIYAIADTAYRSMLQDREDQSILCTGESGAGKTENTKKVIQYLAVVASSHKGKKDTSITGELEKQLLQANPILEAFGNAKTVKNDNSSRFGKFIRINFDVTGYIVGANIETYLLEKSRAIRQARDERTFHIFYYMIAGAKEKMRSDLLLEGFNNYTFLSNGFVPIPAAQDDEMFQETVEAMAIMGFSEEEQLSILKVVSSVLQLGNIVFKKERNTDQASMPDNTAAQKVCHLMGINVTDFTRSILTPRIKVGRDVVQKAQTKEQADFAVEALAKATYERLFRWILTRVNKALDKTHRQGASFLGILDIAGFEIFEVNSFEQLCINYTNEKLQQLFNHTMFILEQEEYQREGIEWNFIDFGLDLQPCIELIERPNNPPGVLALLDEECWFPKATDKSFVEKLCTEQGSHPKFQKPKQLKDKTEFSIIHYAGKVDYNASAWLTKNMDPLNDNVTSLLNASSDKFVADLWKDVDRIVGLDQMAKMTESSLPSASKTKKGMFRTVGQLYKEQLGKLMTTLRNTTPNFVRCIIPNHEKRSGKLDAFLVLEQLRCNGVLEGIRICRQGFPNRIVFQEFRQRYEILAANAIPKGFMDGKQACILMIKALELDPNLYRIGQSKIFFRTGVLAHLEEERDLKITDVIMAFQAMCRGYLARKAFAKRQQQLTAMKVIQRNCAAYLKLRNWQWWRLFTKVKPLLQVTRQEEEMQAKEDELQKTKERQQKAENELKELEQKHSQLTEEKNLLQEQLQAETELYAEAEEMRVRLAAKKQELEEILHEMEARLEEEEDRGQQLQAERKKMAQQMLDLEEQLEEEEAARQKLQLEKVTAEAKIKKLEDEILVMDDQNNKLSKERKLLEERISDLTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKLKRKLEGDASDFHEQIADLQAQIAELKMQLAKKEEELQAALARLDDEIAQKNNALKKIRELEGHISDLQEDLDSERAARNKAEKQKRDLGEELEALKTELEDTLDSTATQQELRAKREQEVTVLKKALDEETRSHEAQVQEMRQKHAQAVEELTEQLEQFKRAKANLDKNKQTLEKENADLAGELRVLGQAKQEVEHKKKKLEAQVQELQSKCSDGERARAELNDKVHKLQNEVESVTGMLNEAEGKAIKLAKDVASLSSQLQDTQELLQEETRQKLNVSTKLRQLEEERNSLQDQLDEEMEAKQNLERHISTLNIQLSDSKKKLQDFASTVEALEEGKKRFQKEIENLTQQYEEKAAAYDKLEKTKNRLQQELDDLVVDLDNQRQLVSNLEKKQRKFDQLLAEEKNISSKYADERDRAEAEAREKETKALSLARALEEALEAKEELERTNKMLKAEMEDLVSSKDDVGKNVHELEKSKRALETQMEEMKTQLEELEDELQATEDAKLRLEVNMQALKGQFERDLQARDEQNEEKRRQLQRQLHEYETELEDERKQRALAAAAKKKLEGDLKDLELQADSAIKGREEAIKQLRKLQAQMKDFQRELEDARASRDEIFATAKENEKKAKSLEADLMQLQEDLAAAERARKQADLEKEELAEELASSLSGRNALQDEKRRLEARIAQLEEELEEEQGNMEAMSDRVRKATQQAEQLSNELATERSTAQKNESARQQLERQNKELRSKLHEMEGAVKSKFKSTIAALEAKIAQLEEQVEQEAREKQAATKSLKQKDKKLKEILLQVEDERKMAEQYKEQAEKGNARVKQLKRQLEEAEEESQRINANRRKLQRELDEATESNEAMGREVNALKSKLRRGNETSFVPSRRSGGRRVIENADGSEEETDTRDADFNGTKASE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
8PhosphorylationMAQKGQLSDDEKFLF
CCCCCCCCCCCCEEE
34.8224972180
23PhosphorylationVDKNFINSPVAQADW
ECCCCCCCHHHHHHH
18.8826657352
40PhosphorylationKRLVWVPSEKQGFEA
HHHEECCCHHCCCEE
48.05-
49PhosphorylationKQGFEAASIKEEKGD
HCCCEECCCCHHHCC
41.0423403867
67AcetylationVELVENGKKVTVGKD
EEEECCCCEEEECHH
56.5030585641
78AcetylationVGKDDIQKMNPPKFS
ECHHHHHHCCCCCCC
40.7622638993
83UbiquitinationIQKMNPPKFSKVEDM
HHHCCCCCCCCCHHH
64.62-
85PhosphorylationKMNPPKFSKVEDMAE
HCCCCCCCCCHHHHH
41.7529514088
94PhosphorylationVEDMAELTCLNEASV
CHHHHHHHHCCHHHH
13.3726657352
100PhosphorylationLTCLNEASVLHNLRE
HHHCCHHHHHHHHHH
21.0223532336
129"N6,N6,N6-trimethyllysine"CVVVNPYKHLPIYSE
EEEECCCCCCCCCCH
39.66-
129MethylationCVVVNPYKHLPIYSE
EEEECCCCCCCCCCH
39.66-
142PhosphorylationSEKIVDMYKGKKRHE
CHHHHHHHCCCCCCC
16.48-
143AcetylationEKIVDMYKGKKRHEM
HHHHHHHCCCCCCCC
58.587668381
146AcetylationVDMYKGKKRHEMPPH
HHHHCCCCCCCCCCC
68.607669835
155PhosphorylationHEMPPHIYAIADTAY
CCCCCCHHHHHHHHH
6.7418083107
162PhosphorylationYAIADTAYRSMLQDR
HHHHHHHHHHHCCCC
12.81-
173PhosphorylationLQDREDQSILCTGES
CCCCCCCCEEEECCC
29.8321712546
176S-palmitoylationREDQSILCTGESGAG
CCCCCEEEECCCCCC
4.3529575903
177PhosphorylationEDQSILCTGESGAGK
CCCCEEEECCCCCCC
40.30-
184UbiquitinationTGESGAGKTENTKKV
ECCCCCCCCCCHHHH
52.73-
194PhosphorylationNTKKVIQYLAVVASS
CHHHHHHHHHHHHHC
5.87-
200PhosphorylationQYLAVVASSHKGKKD
HHHHHHHHCCCCCCC
22.7423312004
201PhosphorylationYLAVVASSHKGKKDT
HHHHHHHCCCCCCCC
21.3423312004
208PhosphorylationSHKGKKDTSITGELE
CCCCCCCCCCCHHHH
30.7923312004
209PhosphorylationHKGKKDTSITGELEK
CCCCCCCCCCHHHHH
28.4326657352
211PhosphorylationGKKDTSITGELEKQL
CCCCCCCCHHHHHHH
25.1127499020
232UbiquitinationLEAFGNAKTVKNDNS
HHHHCCCEECCCCCC
58.8321906983
232UbiquitinationLEAFGNAKTVKNDNS
HHHHCCCEECCCCCC
58.8321906983
233PhosphorylationEAFGNAKTVKNDNSS
HHHCCCEECCCCCCC
34.01-
235UbiquitinationFGNAKTVKNDNSSRF
HCCCEECCCCCCCCC
64.91-
239PhosphorylationKTVKNDNSSRFGKFI
EECCCCCCCCCCEEE
26.2529514088
240PhosphorylationTVKNDNSSRFGKFIR
ECCCCCCCCCCEEEE
37.5729514088
244UbiquitinationDNSSRFGKFIRINFD
CCCCCCCEEEEEEEE
34.60-
255PhosphorylationINFDVTGYIVGANIE
EEEECCEEEECCCHH
5.3118767875
268UbiquitinationIETYLLEKSRAIRQA
HHHHHHHHHHHHHHH
45.25-
269PhosphorylationETYLLEKSRAIRQAR
HHHHHHHHHHHHHHC
19.9818767875
345PhosphorylationFSEEEQLSILKVVSS
CCHHHHHHHHHHHHH
26.1024719451
362AcetylationQLGNIVFKKERNTDQ
HHCCEEEEECCCCCC
42.717665131
363AcetylationLGNIVFKKERNTDQA
HCCEEEEECCCCCCC
50.9019817961
367PhosphorylationVFKKERNTDQASMPD
EEEECCCCCCCCCCC
35.3926329039
371PhosphorylationERNTDQASMPDNTAA
CCCCCCCCCCCCHHH
25.8025159151
376PhosphorylationQASMPDNTAAQKVCH
CCCCCCCHHHHHHHH
30.6526329039
390PhosphorylationHLMGINVTDFTRSIL
HHCCCCCHHCCHHHC
22.4024532841
393PhosphorylationGINVTDFTRSILTPR
CCCCHHCCHHHCCCC
26.7324532841
395PhosphorylationNVTDFTRSILTPRIK
CCHHCCHHHCCCCHH
20.9221406692
398PhosphorylationDFTRSILTPRIKVGR
HCCHHHCCCCHHCCH
14.6221406692
402PhosphorylationSILTPRIKVGRDVVQ
HHCCCCHHCCHHHHH
39.6627251275
491SulfoxidationQQLFNHTMFILEQEE
HHHHHHCHHHCCHHH
1.2128183972
547UbiquitinationWFPKATDKSFVEKLC
CCCCCCCHHHHHHHH
41.25-
548PhosphorylationFPKATDKSFVEKLCT
CCCCCCHHHHHHHHH
37.0224719451
555PhosphorylationSFVEKLCTEQGSHPK
HHHHHHHHCCCCCCC
41.6020860994
559PhosphorylationKLCTEQGSHPKFQKP
HHHHCCCCCCCCCCC
35.9926657352
566PhosphorylationSHPKFQKPKQLKDKT
CCCCCCCCCCCCCCC
20.8827251275
589PhosphorylationGKVDYNASAWLTKNM
CCCCCCCCHHHHCCC
19.1527499020
604PhosphorylationDPLNDNVTSLLNASS
CCCCHHHHHHHHHCC
21.6626657352
605PhosphorylationPLNDNVTSLLNASSD
CCCHHHHHHHHHCCC
26.9526657352
633UbiquitinationVGLDQMAKMTESSLP
HCHHHHHHHCHHCCC
40.80-
637PhosphorylationQMAKMTESSLPSASK
HHHHHCHHCCCCCCH
28.1926657352
638PhosphorylationMAKMTESSLPSASKT
HHHHCHHCCCCCCHH
37.7626657352
641PhosphorylationMTESSLPSASKTKKG
HCHHCCCCCCHHCCC
50.9328509920
643PhosphorylationESSLPSASKTKKGMF
HHCCCCCCHHCCCCC
45.2423312004
645PhosphorylationSLPSASKTKKGMFRT
CCCCCCHHCCCCCHH
35.1823312004
650PhosphorylationSKTKKGMFRTVGQLY
CHHCCCCCHHHHHHH
8.9227251275
652PhosphorylationTKKGMFRTVGQLYKE
HCCCCCHHHHHHHHH
20.0924719451
657PhosphorylationFRTVGQLYKEQLGKL
CHHHHHHHHHHHHHH
12.4620068231
658MethylationRTVGQLYKEQLGKLM
HHHHHHHHHHHHHHH
47.8051082281
666PhosphorylationEQLGKLMTTLRNTTP
HHHHHHHHHHHCCCC
32.8724719451
667PhosphorylationQLGKLMTTLRNTTPN
HHHHHHHHHHCCCCC
15.1124719451
678S-palmitoylationTTPNFVRCIIPNHEK
CCCCCEEEECCCCCC
2.5129575903
687PhosphorylationIPNHEKRSGKLDAFL
CCCCCCCCCCCCHHH
51.8826657352
718MethylationCRQGFPNRIVFQEFR
HHCCCCCCCCHHHHH
27.04-
761PhosphorylationLELDPNLYRIGQSKI
HHCCCCHHHHCCCCH
13.5623917254
766PhosphorylationNLYRIGQSKIFFRTG
CHHHHCCCCHHHHCC
23.62-
767AcetylationLYRIGQSKIFFRTGV
HHHHCCCCHHHHCCH
35.33-
767UbiquitinationLYRIGQSKIFFRTGV
HHHHCCCCHHHHCCH
35.33-
826PhosphorylationIQRNCAAYLKLRNWQ
HHHHHHHHHHHCCHH
5.9528152594
828UbiquitinationRNCAAYLKLRNWQWW
HHHHHHHHHCCHHHH
32.5021906983
828AcetylationRNCAAYLKLRNWQWW
HHHHHHHHHCCHHHH
32.5024502337
828UbiquitinationRNCAAYLKLRNWQWW
HHHHHHHHHCCHHHH
32.5021906983
842UbiquitinationWRLFTKVKPLLQVTR
HHHHHCHHHHHHHHH
31.35-
881AcetylationELKELEQKHSQLTEE
HHHHHHHHHHHHHHH
35.5327178108
883PhosphorylationKELEQKHSQLTEEKN
HHHHHHHHHHHHHHH
33.6426657352
886PhosphorylationEQKHSQLTEEKNLLQ
HHHHHHHHHHHHHHH
34.1723312004
900PhosphorylationQEQLQAETELYAEAE
HHHHHHHHHHHHHHH
34.01-
903PhosphorylationLQAETELYAEAEEMR
HHHHHHHHHHHHHHH
9.00-
968UbiquitinationEEEAARQKLQLEKVT
HHHHHHHHHHHHHHH
32.42-
1009PhosphorylationKLLEERISDLTTNLA
HHHHHHHHHHHHCHH
32.5626657352
1012PhosphorylationEERISDLTTNLAEEE
HHHHHHHHHCHHHHH
20.7329514088
1013PhosphorylationERISDLTTNLAEEEE
HHHHHHHHCHHHHHH
35.2229514088
1016PhosphorylationSDLTTNLAEEEEKAK
HHHHHCHHHHHHHHH
24.9927251275
1034PhosphorylationKLKNKHESMISELEV
HHCHHHHHHHHHHHH
22.5726657352
1041PhosphorylationSMISELEVRLKKEEK
HHHHHHHHHHHHHHH
15.7927251275
1059UbiquitinationELEKLKRKLEGDASD
HHHHHHHHHHCCHHH
49.67-
1065PhosphorylationRKLEGDASDFHEQIA
HHHHCCHHHHHHHHH
45.6226657352
1088AcetylationLKMQLAKKEEELQAA
HHHHHHHCHHHHHHH
65.8372623995
1088UbiquitinationLKMQLAKKEEELQAA
HHHHHHHCHHHHHHH
65.83-
1111AcetylationAQKNNALKKIRELEG
HHHHHHHHHHHHHHC
43.687668389
1121PhosphorylationRELEGHISDLQEDLD
HHHHCHHHHHHHHHH
26.9626657352
1153PhosphorylationEELEALKTELEDTLD
HHHHHHHHHHHHHHC
46.8022199227
1158PhosphorylationLKTELEDTLDSTATQ
HHHHHHHHHCCHHHH
24.0822817901
1161PhosphorylationELEDTLDSTATQQEL
HHHHHHCCHHHHHHH
24.0526657352
1162PhosphorylationLEDTLDSTATQQELR
HHHHHCCHHHHHHHH
33.1326657352
1164PhosphorylationDTLDSTATQQELRAK
HHHCCHHHHHHHHHH
30.7622210691
1177PhosphorylationAKREQEVTVLKKALD
HHHHHHHHHHHHHCC
21.26-
1187PhosphorylationKKALDEETRSHEAQV
HHHCCHHHHHHHHHH
35.1123312004
1189PhosphorylationALDEETRSHEAQVQE
HCCHHHHHHHHHHHH
32.8526657352
1209PhosphorylationAQAVEELTEQLEQFK
HHHHHHHHHHHHHHH
25.6028258704
1216AcetylationTEQLEQFKRAKANLD
HHHHHHHHHHHHHHH
51.667668397
1226UbiquitinationKANLDKNKQTLEKEN
HHHHHHHHHHHHHHC
50.85-
1266PhosphorylationAQVQELQSKCSDGER
HHHHHHHHHCCHHHH
48.5323312004
1291PhosphorylationKLQNEVESVTGMLNE
HHHHHHHHHHHHCHH
30.1026657352
1293PhosphorylationQNEVESVTGMLNEAE
HHHHHHHHHHCHHHH
26.5926657352
1298PhosphorylationSVTGMLNEAEGKAIK
HHHHHCHHHHHHHHH
44.1027251275
1312PhosphorylationKLAKDVASLSSQLQD
HHHHHHHHHHHHHHH
28.7426657352
1314PhosphorylationAKDVASLSSQLQDTQ
HHHHHHHHHHHHHHH
17.3426657352
1315PhosphorylationKDVASLSSQLQDTQE
HHHHHHHHHHHHHHH
39.9626657352
1335PhosphorylationTRQKLNVSTKLRQLE
HHHHCCHHHHHHHHH
20.8223312004
1336PhosphorylationRQKLNVSTKLRQLEE
HHHCCHHHHHHHHHH
29.8023312004
1347O-linked_GlycosylationQLEEERNSLQDQLDE
HHHHHHHHHHHHHHH
33.3628411811
1347PhosphorylationQLEEERNSLQDQLDE
HHHHHHHHHHHHHHH
33.3626657352
1354PhosphorylationSLQDQLDEEMEAKQN
HHHHHHHHHHHHHHH
68.7627251275
1367PhosphorylationQNLERHISTLNIQLS
HHHHHHHHHHEEECC
22.2526657352
1368PhosphorylationNLERHISTLNIQLSD
HHHHHHHHHEEECCC
24.1828857561
1374PhosphorylationSTLNIQLSDSKKKLQ
HHHEEECCCCHHHHH
24.3826657352
1377AcetylationNIQLSDSKKKLQDFA
EEECCCCHHHHHHHH
59.947664345
1378AcetylationIQLSDSKKKLQDFAS
EECCCCHHHHHHHHH
63.777669847
1385PhosphorylationKKLQDFASTVEALEE
HHHHHHHHHHHHHHH
32.7426657352
1386PhosphorylationKLQDFASTVEALEEG
HHHHHHHHHHHHHHH
20.9528857561
1395AcetylationEALEEGKKRFQKEIE
HHHHHHHHHHHHHHH
70.117668405
1405PhosphorylationQKEIENLTQQYEEKA
HHHHHHHHHHHHHHH
25.80-
1408PhosphorylationIENLTQQYEEKAAAY
HHHHHHHHHHHHHHH
19.0826657352
1415PhosphorylationYEEKAAAYDKLEKTK
HHHHHHHHHHHHHHH
14.6426657352
1421PhosphorylationAYDKLEKTKNRLQQE
HHHHHHHHHHHHHHH
24.95-
1444PhosphorylationDNQRQLVSNLEKKQR
HHHHHHHHHHHHHHH
44.2726657352
1448AcetylationQLVSNLEKKQRKFDQ
HHHHHHHHHHHHHHH
58.327672231
1449AcetylationLVSNLEKKQRKFDQL
HHHHHHHHHHHHHHH
46.067669859
1452AcetylationNLEKKQRKFDQLLAE
HHHHHHHHHHHHHHH
51.2972594365
1452MethylationNLEKKQRKFDQLLAE
HHHHHHHHHHHHHHH
51.2972594365
1452UbiquitinationNLEKKQRKFDQLLAE
HHHHHHHHHHHHHHH
51.29-
1465PhosphorylationAEEKNISSKYADERD
HHHHCCCHHHHHHHH
26.37-
1467PhosphorylationEKNISSKYADERDRA
HHCCCHHHHHHHHHH
22.6418083107
1484AcetylationEAREKETKALSLARA
HHHHHHHHHHHHHHH
48.7111922559
1484UbiquitinationEAREKETKALSLARA
HHHHHHHHHHHHHHH
48.71-
1487PhosphorylationEKETKALSLARALEE
HHHHHHHHHHHHHHH
25.5028060719
1518PhosphorylationAEMEDLVSSKDDVGK
HHHHHHHCCCCHHCC
38.6823312004
1519PhosphorylationEMEDLVSSKDDVGKN
HHHHHHCCCCHHCCH
32.4023312004
1539PhosphorylationKSKRALETQMEEMKT
HHHHHHHHHHHHHHH
33.7819060867
1546PhosphorylationTQMEEMKTQLEELED
HHHHHHHHHHHHHHH
36.7621082442
1558PhosphorylationLEDELQATEDAKLRL
HHHHHHCCHHHHHHH
22.80-
1562UbiquitinationLQATEDAKLRLEVNM
HHCCHHHHHHHHHHH
46.60-
1601PhosphorylationLQRQLHEYETELEDE
HHHHHHHHHHHCHHH
19.8723312004
1603PhosphorylationRQLHEYETELEDERK
HHHHHHHHHCHHHHH
44.9923312004
1619AcetylationRALAAAAKKKLEGDL
HHHHHHHHHHHCCCH
45.797668417
1635PhosphorylationDLELQADSAIKGREE
HHHHHHHHHHCCHHH
34.6026657352
1649UbiquitinationEAIKQLRKLQAQMKD
HHHHHHHHHHHHHHH
54.25-
1667PhosphorylationELEDARASRDEIFAT
HHHHHHHCHHHHHHH
34.4126657352
1674PhosphorylationSRDEIFATAKENEKK
CHHHHHHHHHHHHHH
27.7523312004
1680AcetylationATAKENEKKAKSLEA
HHHHHHHHHHHHHHH
70.397669871
1681AcetylationTAKENEKKAKSLEAD
HHHHHHHHHHHHHHH
55.677668429
1684PhosphorylationENEKKAKSLEADLMQ
HHHHHHHHHHHHHHH
35.9827499020
1701MethylationEDLAAAERARKQADL
HHHHHHHHHHHHHHH
34.66115385365
1719PhosphorylationELAEELASSLSGRNA
HHHHHHHHHHCCCHH
44.4227251275
1720PhosphorylationLAEELASSLSGRNAL
HHHHHHHHHCCCHHH
22.4327251275
1722PhosphorylationEELASSLSGRNALQD
HHHHHHHCCCHHHHH
37.3427251275
1729PhosphorylationSGRNALQDEKRRLEA
CCCHHHHHHHHHHHH
65.3227251275
1731AcetylationRNALQDEKRRLEARI
CHHHHHHHHHHHHHH
51.627669883
1756PhosphorylationQGNMEAMSDRVRKAT
HCCHHHHHHHHHHHH
29.3426657352
1763PhosphorylationSDRVRKATQQAEQLS
HHHHHHHHHHHHHHH
25.0123403867
1770PhosphorylationTQQAEQLSNELATER
HHHHHHHHHHHHHHH
28.1426657352
1775PhosphorylationQLSNELATERSTAQK
HHHHHHHHHHHHHHH
44.5523403867
1810PhosphorylationEMEGAVKSKFKSTIA
HHHHHHHHHHHHHHH
36.4020860994
1811AcetylationMEGAVKSKFKSTIAA
HHHHHHHHHHHHHHH
51.607680073
1813AcetylationGAVKSKFKSTIAALE
HHHHHHHHHHHHHHH
50.887680085
1814PhosphorylationAVKSKFKSTIAALEA
HHHHHHHHHHHHHHH
28.3320068231
1815PhosphorylationVKSKFKSTIAALEAK
HHHHHHHHHHHHHHH
18.4120068231
1868PhosphorylationERKMAEQYKEQAEKG
HHHHHHHHHHHHHHH
14.16-
1925MethylationGREVNALKSKLRRGN
HHHHHHHHHHHHCCC
43.04-
1934PhosphorylationKLRRGNETSFVPSRR
HHHCCCCCCCCCCCC
31.3123532336
1935PhosphorylationLRRGNETSFVPSRRS
HHCCCCCCCCCCCCC
20.3328857561
1937 (in isoform 4)Phosphorylation-4.1624670416
1939PhosphorylationNETSFVPSRRSGGRR
CCCCCCCCCCCCCCE
34.7226657352
1942PhosphorylationSFVPSRRSGGRRVIE
CCCCCCCCCCCEEEE
44.4826657352
1944 (in isoform 3)Phosphorylation-18.5724670416
1954PhosphorylationVIENADGSEEETDTR
EEECCCCCCCCCCCC
42.2423911959
1958PhosphorylationADGSEEETDTRDADF
CCCCCCCCCCCCCCC
46.0526657352
1960PhosphorylationGSEEETDTRDADFNG
CCCCCCCCCCCCCCC
37.5630242111
1961PhosphorylationSEEETDTRDADFNGT
CCCCCCCCCCCCCCC
39.6724719451
1968PhosphorylationRDADFNGTKASE---
CCCCCCCCCCCC---
25.2528857561
1971PhosphorylationDFNGTKASE------
CCCCCCCCC------
100.00-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of MYH11_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MYH11_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MYH11_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MYO1E_HUMANMYO1Ephysical
22939629
C4BPA_HUMANC4BPAphysical
26496610
CAPZB_HUMANCAPZBphysical
26496610
FLNA_HUMANFLNAphysical
26496610
MYL6_HUMANMYL6physical
26496610
RAD51_HUMANRAD51physical
26496610
SVIL_HUMANSVILphysical
26496610
1433E_HUMANYWHAEphysical
26496610
ARPC5_HUMANARPC5physical
26496610
ARP3_HUMANACTR3physical
26496610
RBP1_HUMANRALBP1physical
26496610
POC1A_HUMANPOC1Aphysical
26496610
ASTE1_HUMANASTE1physical
26496610
MED4_HUMANMED4physical
26496610
LRC59_HUMANLRRC59physical
26496610
CING_HUMANCGNphysical
26496610
INF2_HUMANINF2physical
26496610
ARP5L_HUMANARPC5Lphysical
26496610
TBC31_HUMANTBC1D31physical
26496610
UBX2A_HUMANUBXN2Aphysical
26496610
PLBL2_HUMANPLBD2physical
26496610
TM189_HUMANTMEM189physical
26496610

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
Note=A chromosomal aberration involving MYH11 is found in acute myeloid leukemia of M4EO subtype. Pericentric inversion inv(16)(p13
q22). The inversion produces a fusion protein consisting of the 165 N-terminal residues of CBF-beta (PEPB2) and the tail region of MYH11.
132900
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MYH11_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography.";
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.;
Proteomics 8:1346-1361(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1954, AND MASSSPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1539 AND THR-1546, ANDMASS SPECTROMETRY.

TOP